Pyrazolopyrimidine compound

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 487/04 (2006.01) A61K 31/519 (2006.01) A61K 31/5377 (2006.01) A61K 31/538 (2006.01) A61K 31/541 (2006.01) A61K 31/55 (2006.01) A61K 31/553 (2006.01) A61P 19/02 (2006.01) A61P 37/06 (2006.01) A61P 37/08 (2006.01) A61P 43/00 (2006.01) C07D 519/00 (2006.01)

Patent

CA 2673965

Disclosed is a novel compound having Syk and/or Abl inhibitory activities, which is useful for prevention/treatment of allergic diseases, autoimmune diseases, arthritides and cancers. Specifically disclosed is a pyrazolopyrimidine compound represented by the formula [I] or [III] below, a tautomer thereof, a stereoisomer thereof, a pharmaceutically acceptable salt thereof, or a solvate of any of them.

L'invention concerne un nouveau composé ayant des activités inhibitrices de Syk et/ou Abl. Ce composé est utile pour la prévention/traitement de maladies allergiques, de maladies auto-immunes, de l'arthrite et de cancers. L'invention concerne spécifiquement un composé pyrazolopyrimidine représenté par la formule [I] ou [III] ci-après, un tautomère de celui-ci, un stéréoisomère de celui-ci, un sel pharmaceutiquement acceptable de celui-ci ou un solvate de l'un quelconque de ceux-ci.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Pyrazolopyrimidine compound does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pyrazolopyrimidine compound, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyrazolopyrimidine compound will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1742689

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.